fluconazole has been researched along with Pneumonia in 45 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The current recommended therapy for diffuse coccidioidal pneumonia involves initial treatment with amphotericin B deoxycholate or high-dose fluconazole, followed by an azole after clinical improvement." | 7.73 | Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. ( Cheong, HJ; Kim, JH; Kim, MJ; Kim, WJ; Park, DW; Shin, C; Sohn, JW, 2006) |
| "Twenty-two patients with AIDS and various forms of cryptococcosis were treated in an open-label study with 50 to 400 mg/day of fluconazole." | 7.67 | Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. ( Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ, 1988) |
| "Aspergillus infection is the most frequent fungal infection associated with chronic granulomatous disease (CGD), and often results in a life-threatening situation." | 5.28 | [Effect of fluconazole on Aspergillus infection associated with chronic granulomatous disease]. ( Kawamori, J; Tsuruta, S; Yoshida, T, 1991) |
| " The patient in this case responded to isavuconazole treatment for breakthrough infection due to B raffinosifermentans that was cultured from pleural fluid while on posaconazole prophylaxis post-bilateral lung transplantation for cystic fibrosis." | 5.12 | Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature. ( Al-Obaidi, M; Badali, H; Cañete-Gibas, C; Patterson, HP; Wiederhold, NP, 2021) |
| " The onset of his hypoglycemia occurred within days after starting voriconazole and subsequently fluconazole for a fungal pneumonia." | 3.88 | Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. ( Austin, E; Gunaratne, K; Wu, PE, 2018) |
| " Fluconazole was continued until serum cryptococcal antigen (SCA) levels were negative in our patients as they had manifestations such as haemoptysis, cavitating or multi-lobar pneumonia and relatively high antigen levels, suggesting potentially serious disease." | 3.73 | Cavitating cryptococcal pneumonia in the immunocompetent host. ( Eng, P; Hsu, AA; Koh, MS; Kurup, A; Tan, BH, 2005) |
| "The current recommended therapy for diffuse coccidioidal pneumonia involves initial treatment with amphotericin B deoxycholate or high-dose fluconazole, followed by an azole after clinical improvement." | 3.73 | Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. ( Cheong, HJ; Kim, JH; Kim, MJ; Kim, WJ; Park, DW; Shin, C; Sohn, JW, 2006) |
| " Coccidioidomycosis was suspected and empirically treated with fluconazole." | 3.72 | Coccidioidal pneumonia, arthritis, and soft-tissue infection after kidney transplantation. ( Blair, JE, 2004) |
| " He received broad-spectrum antibiotics, fluconazole for oral candidiasis, and cotrimoxazole for possible Pneumocystis carinii." | 3.71 | Pneumonia due to Candida krusei. ( Costopoulos, H; Georgilis, K; Kontoyannis, D; Nanas, J; Petrocheilou-Paschou, V; Prifti, H; Stamatelopoulos, S, 2002) |
| "Twenty-two patients with AIDS and various forms of cryptococcosis were treated in an open-label study with 50 to 400 mg/day of fluconazole." | 3.67 | Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. ( Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ, 1988) |
| "We present a case of a patient with hairy cell leukemia and pulmonary aspergillosis who developed a cycotic pulmonary artery aneurysm despite prolonged antifungal therapy." | 2.46 | Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature. ( Erasmus, J; Mattiuzzi, GN; Sever, M; Verstovsek, S, 2010) |
| "Currently, cancer patients with microbial infection are a severe challenge in clinical treatment." | 1.72 | Synthesis of Hemiprotonic Phenanthroline-Phenanthroline ( Cui, Z; Fu, A; Fu, C; Keerthiga, R; Li, X; Tong, T; Yang, X; Zhang, Y; Zhao, Z, 2022) |
| "Although "Candida pneumonia" is rarely being reported in critically ill patients, Candida airway colonization mainly by Candida albicans is common especially among patients with diabetes, malignancies, and kidney disorders." | 1.72 | Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia. ( Amiri, S; Erami, M; Fakhrehi, M; Getso, MI; Hashemi, SJ; Mehri, N; Momen-Heravi, M; Raiesi, O; Raissi, V; Yarahmadi, M, 2022) |
| "Fungal pneumonia is considered as one of the most serious forms of pneumonia, the number of which has recently increased despite the use of new antimycotic drugs in pulmonology." | 1.48 | [CASE REPORT OF CANDIDA PNEUMONIA]. ( Beysenbekova, Z; Tayzhanova, D; Toleuova, A; Toyynbekova, R, 2018) |
| "Bacterial pneumonia is a common cause of death worldwide." | 1.46 | Pulmonary delivery of tea tree oil-β-cyclodextrin inclusion complexes for the treatment of fungal and bacterial pneumonia. ( Du, L; Jin, Y; Li, M; Liu, B; Zhang, T; Zhu, L, 2017) |
| "The relationship between pulmonary Cryptococcus infection and breast cancer is also discussed." | 1.36 | Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection. ( Cheng, YL; Hsu, GC; Hsu, HM; Hsu, KF; Ou, KW; Yu, JC, 2010) |
| "After this treatment, pneumonia deteriorated." | 1.29 | [Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report]. ( Maezawa, H; Nakazawa, Y; Saito, A; Sakai, O; Sakamoto, M; Shiba, K; Shindou, N; Yoshida, M; Yoshikawa, K, 1993) |
| "Case 2 was a boy with candida pneumonitis." | 1.29 | [Fluconazole therapy for pediatric patients with severe candidal infections]. ( Hisakawa, H; Kurashige, T; Misaki, Y; Morita, H; Okada, T; Sinohara, M; Tomoda, T; Wakiguchi, H; Watanabe, S, 1994) |
| "Aspergillus infection is the most frequent fungal infection associated with chronic granulomatous disease (CGD), and often results in a life-threatening situation." | 1.28 | [Effect of fluconazole on Aspergillus infection associated with chronic granulomatous disease]. ( Kawamori, J; Tsuruta, S; Yoshida, T, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.22) | 18.7374 |
| 1990's | 11 (24.44) | 18.2507 |
| 2000's | 12 (26.67) | 29.6817 |
| 2010's | 16 (35.56) | 24.3611 |
| 2020's | 5 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Z | 1 |
| Li, X | 1 |
| Cui, Z | 1 |
| Tong, T | 1 |
| Zhang, Y | 2 |
| Yang, X | 1 |
| Keerthiga, R | 1 |
| Fu, C | 1 |
| Fu, A | 1 |
| Erami, M | 1 |
| Raiesi, O | 1 |
| Momen-Heravi, M | 1 |
| Getso, MI | 1 |
| Fakhrehi, M | 1 |
| Mehri, N | 1 |
| Yarahmadi, M | 1 |
| Amiri, S | 1 |
| Raissi, V | 1 |
| Hashemi, SJ | 1 |
| Oladele, RO | 1 |
| Ettu, AO | 1 |
| Medugu, N | 1 |
| Habib, A | 1 |
| Egbagbe, E | 1 |
| Osinaike, T | 1 |
| Makanjuola, OB | 1 |
| Ogunbosi, B | 1 |
| Irowa, OO | 1 |
| Ejembi, J | 1 |
| Uwaezuoke, NS | 1 |
| Adeleke, G | 1 |
| Mutiu, B | 1 |
| Ogunsola, F | 1 |
| Rotimi, V | 1 |
| Allano, M | 1 |
| Grimes, C | 1 |
| Boivin, R | 1 |
| Smith, G | 1 |
| Dumaresq, J | 1 |
| Leclere, M | 1 |
| Oltean, HN | 1 |
| Springer, M | 1 |
| Bowers, JR | 1 |
| Barnes, R | 1 |
| Reid, G | 1 |
| Valentine, M | 1 |
| Engelthaler, DM | 1 |
| Toda, M | 1 |
| McCotter, OZ | 1 |
| Al-Obaidi, M | 1 |
| Badali, H | 1 |
| Cañete-Gibas, C | 1 |
| Patterson, HP | 1 |
| Wiederhold, NP | 1 |
| Wheeler, DJ | 1 |
| Cascino, T | 1 |
| Sharpe, BA | 1 |
| Connor, DM | 1 |
| Li, M | 1 |
| Zhu, L | 1 |
| Zhang, T | 1 |
| Liu, B | 1 |
| Du, L | 1 |
| Jin, Y | 1 |
| Toleuova, A | 1 |
| Tayzhanova, D | 1 |
| Toyynbekova, R | 1 |
| Beysenbekova, Z | 1 |
| Gunaratne, K | 1 |
| Austin, E | 1 |
| Wu, PE | 1 |
| Viriyakosol, S | 1 |
| Kapoor, M | 1 |
| Okamoto, S | 1 |
| Covel, J | 1 |
| Soltow, QA | 1 |
| Trzoss, M | 1 |
| Shaw, KJ | 1 |
| Fierer, J | 1 |
| Beatty, NL | 1 |
| Hanzlik, TP | 1 |
| Connick, E | 1 |
| Asadi Gharabaghi, M | 1 |
| Allameh, SF | 1 |
| Cicora, F | 1 |
| Petroni, J | 1 |
| Formosa, P | 1 |
| Roberti, J | 1 |
| Mohamed, AM | 1 |
| Waheed, SA | 1 |
| Mohamed, NM | 1 |
| Clark, NM | 1 |
| Sharma, V | 1 |
| De, A | 1 |
| Ahuja, A | 1 |
| Lamoria, S | 1 |
| Lamba, BM | 1 |
| Roan, JN | 1 |
| Hsieh, HY | 1 |
| Tsai, HW | 1 |
| Wu, CJ | 1 |
| Hsu, CH | 1 |
| Wu, SY | 1 |
| Yang, YJ | 1 |
| Chang, TC | 1 |
| Ou, KW | 1 |
| Hsu, KF | 1 |
| Cheng, YL | 1 |
| Hsu, GC | 1 |
| Hsu, HM | 1 |
| Yu, JC | 1 |
| Sever, M | 1 |
| Verstovsek, S | 1 |
| Erasmus, J | 1 |
| Mattiuzzi, GN | 1 |
| Gill, PK | 1 |
| Gill, JS | 1 |
| Aruch, DB | 1 |
| Bhusal, Y | 1 |
| Hamill, RJ | 1 |
| Rankin, BT | 1 |
| Jariwala, S | 1 |
| Petrocheilou-Paschou, V | 1 |
| Georgilis, K | 1 |
| Kontoyannis, D | 1 |
| Nanas, J | 1 |
| Prifti, H | 1 |
| Costopoulos, H | 1 |
| Stamatelopoulos, S | 1 |
| Shrestha, RK | 1 |
| Stoller, JK | 1 |
| Honari, G | 1 |
| Procop, GW | 1 |
| Gordon, SM | 1 |
| Arend, SM | 1 |
| Kuijper, EJ | 1 |
| Allaart, CF | 1 |
| Muller, WH | 1 |
| Van Dissel, JT | 1 |
| Blair, JE | 1 |
| Wang, CY | 1 |
| Jerng, JS | 1 |
| Ko, JC | 1 |
| Lin, MF | 1 |
| Hsiao, CH | 1 |
| Lee, LN | 1 |
| Hsueh, PR | 1 |
| Kuo, SH | 1 |
| Mele, G | 1 |
| Musci, M | 1 |
| Musto, C | 1 |
| D'Amato, L | 1 |
| Traficante, A | 1 |
| Di Renzo, N | 1 |
| Koh, MS | 1 |
| Tan, BH | 1 |
| Kurup, A | 1 |
| Hsu, AA | 1 |
| Eng, P | 1 |
| Park, DW | 1 |
| Sohn, JW | 1 |
| Cheong, HJ | 1 |
| Kim, WJ | 1 |
| Kim, MJ | 1 |
| Kim, JH | 1 |
| Shin, C | 1 |
| Tascini, C | 1 |
| Ferranti, S | 1 |
| Leonildi, A | 1 |
| Menichetti, F | 1 |
| Yoshida, M | 1 |
| Yoshikawa, K | 1 |
| Maezawa, H | 1 |
| Shindou, N | 1 |
| Sakamoto, M | 1 |
| Nakazawa, Y | 1 |
| Shiba, K | 1 |
| Saito, A | 1 |
| Sakai, O | 1 |
| Wakiguchi, H | 1 |
| Hisakawa, H | 1 |
| Sinohara, M | 1 |
| Watanabe, S | 1 |
| Okada, T | 1 |
| Misaki, Y | 1 |
| Tomoda, T | 1 |
| Morita, H | 1 |
| Kurashige, T | 1 |
| Inoue, N | 1 |
| Takemoto, Y | 1 |
| Kanamaru, A | 1 |
| Kakishita, E | 1 |
| Nakayama, S | 1 |
| Hara, H | 1 |
| Tsutsui, T | 1 |
| Murakami, R | 1 |
| Yamaguchi, N | 1 |
| Tago, H | 1 |
| Weinroth, SE | 1 |
| Tuazon, CU | 1 |
| Meis, JF | 1 |
| Donnelly, JP | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| De Pauw, BE | 1 |
| Vassallo, J | 1 |
| Galizia, AC | 1 |
| Cuschieri, P | 1 |
| Mirels, LF | 1 |
| Stevens, DA | 1 |
| Weber, C | 1 |
| Maas, R | 1 |
| Steiner, P | 1 |
| Kramer, J | 1 |
| Bumann, D | 1 |
| Zander, AR | 1 |
| Bücheler, E | 1 |
| Matsumoto, K | 1 |
| Ueno, K | 1 |
| Yoshimura, H | 1 |
| Morii, M | 1 |
| Takada, M | 1 |
| Sawai, T | 1 |
| Mitsutake, K | 1 |
| Shibakawa, M | 1 |
| Friese, G | 1 |
| Discher, T | 1 |
| Füssle, R | 1 |
| Schmalreck, A | 1 |
| Lohmeyer, J | 1 |
| Sotoyama, K | 1 |
| Kawamori, J | 1 |
| Tsuruta, S | 1 |
| Yoshida, T | 1 |
| Quist, P | 1 |
| Tauris, P | 1 |
| Stern, JJ | 1 |
| Hartman, BJ | 1 |
| Sharkey, P | 1 |
| Rowland, V | 1 |
| Squires, KE | 1 |
| Murray, HW | 1 |
| Graybill, JR | 1 |
2 reviews available for fluconazole and Pneumonia
| Article | Year |
|---|---|
Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Female; Fluconazole; Genes, Fungal; Human | 2021 |
Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature.
Topics: Abscess; Acyclovir; Amphotericin B; Aneurysm, Infected; Anti-Bacterial Agents; Antifungal Agents; An | 2010 |
1 trial available for fluconazole and Pneumonia
| Article | Year |
|---|---|
[An evaluation of a therapy with antibacterial and antifungal agents infections with hematological disorders].
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Cefoperazone; Child; Child, Prescho | 1993 |
42 other studies available for fluconazole and Pneumonia
| Article | Year |
|---|---|
Synthesis of Hemiprotonic Phenanthroline-Phenanthroline
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Apo | 2022 |
Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Caspofu | 2022 |
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acqu | 2023 |
Topics: Animals; Canada; Cryptococcosis; Cryptococcus gattii; Fluconazole; Horse Diseases; Horses; Male; Pne | 2019 |
Suspected Locally Acquired Coccidioidomycosis in Human, Spokane, Washington, USA.
Topics: Aged, 80 and over; Antifungal Agents; Coccidioides; Coccidioidomycosis; Cough; Diagnosis, Differenti | 2020 |
When the Script Doesn't Fit: An Exercise in Clinical Reasoning.
Topics: Adult; Antifungal Agents; Chest Pain; Coccidioidomycosis; Community-Acquired Infections; Diagnosis, | 2017 |
Pulmonary delivery of tea tree oil-β-cyclodextrin inclusion complexes for the treatment of fungal and bacterial pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antifungal Agents | 2017 |
[CASE REPORT OF CANDIDA PNEUMONIA].
Topics: Adolescent; Antifungal Agents; Candida albicans; Candidiasis; Delayed Diagnosis; Fluconazole; Humans | 2018 |
Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report.
Topics: Antifungal Agents; Diabetes Mellitus, Type 2; Drug Interactions; Fluconazole; Gliclazide; Humans; Hy | 2018 |
APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental
Topics: Aminopyridines; Amphotericin B; Animals; Antifungal Agents; Coccidioides; Disease Models, Animal; Fe | 2019 |
West African Man with a Cavitary Pneumonia and Cutaneous Nodule.
Topics: Adult; Antibodies, Fungal; Arizona; Biopsy; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; I | 2019 |
Primary pulmonary cryptococcosis.
Topics: Adult; Antifungal Agents; Cryptococcosis; Female; Fluconazole; Humans; Pneumonia; Postpartum Period | 2014 |
A rare case of Cryptococcus gattii pneumonia in a renal transplant patient.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Fluconazole; Humans; Kidney Transplan | 2015 |
An 87-Year-Old Man with Acute Catastrophic Pneumonia.
Topics: Acute Disease; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Burkholderia cepacia; Ca | 2016 |
Acute Esophageal Necrosis Caused by Candidiasis in a Patient with Systemic Lupus Erythematosus.
Topics: Adult; Anti-Bacterial Agents; Candidiasis; Endoscopy, Digestive System; Esophagus; Female; Fluconazo | 2016 |
Pulmonary nodules caused by Schizophyllum commune after cardiac transplantation.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Female; Fluconazole; Heart Transplantation; H | 2009 |
Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection.
Topics: Antifungal Agents; Antigens, Fungal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cryptococcosis; Cr | 2010 |
Blastoschizomyces capitatus pneumonia in an immuno-competent female.
Topics: Aged; Antifungal Agents; Diagnosis, Differential; Female; Fluconazole; Humans; Immunocompetence; Lun | 2011 |
Unusual cause of cellulitis in a patient with hepatitis C and cirrhosis.
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neof | 2011 |
Graded challenge protocol for fluconazole hypersensitivity in a patient with cryptococcal pneumonitis.
Topics: Administration, Oral; Adult; Antifungal Agents; Cryptococcosis; Desensitization, Immunologic; Diphen | 2012 |
Pneumonia due to Candida krusei.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Candida; Candidiasis; Fatal | 2002 |
Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel.
Topics: Aged; Animals; Animals, Domestic; Antibodies, Monoclonal; Antifungal Agents; Antirheumatic Agents; A | 2004 |
Cavitating pneumonia after treatment with infliximab and prednisone.
Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; Cryptococcosis; Female; Fluconazole; Follow-Up Studie | 2004 |
Coccidioidal pneumonia, arthritis, and soft-tissue infection after kidney transplantation.
Topics: Antifungal Agents; Arthritis, Infectious; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; Kid | 2004 |
Disseminated coccidioidomycosis.
Topics: Aged; Antifungal Agents; Coccidioides; Coccidioidomycosis; Drug Resistance, Fungal; Fluconazole; Fun | 2005 |
Pneumonia caused by Trichosporon pullulans in an autologous peripheral blood stem cell transplant recipient: possible misidentification.
Topics: Aged; Cryptococcus; Diagnostic Errors; Fluconazole; Humans; Male; Peripheral Blood Stem Cell Transpl | 2005 |
Cavitating cryptococcal pneumonia in the immunocompetent host.
Topics: Adult; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Immunocompetence; Male; Middle Aged; | 2005 |
Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole.
Topics: Adult; Antifungal Agents; Caspofungin; Coccidioidomycosis; Drug Therapy, Combination; Echinocandins; | 2006 |
Breakthrough Fusarium sp probable pneumonia during fluconazole therapy in an AIDS patient with diabetes, candidemia, Pneumocystis carinii pneumonia and cytomegalovirus disseminated infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Cytomegalovirus Infections; D | 2006 |
[Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fl | 1993 |
[Fluconazole therapy for pediatric patients with severe candidal infections].
Topics: Adolescent; Candidiasis; Child; Esophagitis; Female; Fluconazole; Humans; Lung Diseases, Fungal; Mal | 1994 |
Alopecia associated with fluconazole treatment.
Topics: Aged; Alopecia; Cryptococcosis; Female; Fluconazole; Humans; Pneumonia | 1993 |
Aspergillus fumigatus pneumonia in neutropenic patients during therapy with fluconazole for infection due to Candida species.
Topics: Adolescent; Adult; Aged; Aspergillosis; Aspergillus fumigatus; Candidiasis; Female; Fluconazole; Hum | 1993 |
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination | 1996 |
Update on treatment of coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Immunocompromised Host; | 1997 |
[Importance of digital thoracic radiography in the diagnosis of pulmonary infiltrates in patients with bone marrow transplantation during aplasia].
Topics: Adult; Anemia, Aplastic; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Bone Marr | 1999 |
Fluconazole-induced convulsions at serum trough concentrations of approximately 80 microg/mL.
Topics: Aged; Antifungal Agents; Candidiasis; Drug Administration Schedule; Female; Fluconazole; Humans; Mal | 2000 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cr | 2001 |
[Countermeasure for infections with granulocytopenia].
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Candidiasis; Cephalosporins; Drug Therapy, | 1992 |
[Effect of fluconazole on Aspergillus infection associated with chronic granulomatous disease].
Topics: Aspergillosis; Aspergillus fumigatus; Child, Preschool; Fluconazole; Granulomatous Disease, Chronic; | 1991 |
Short-term curative treatment of Aspergillus fumigatus pneumonia with fluconazole.
Topics: Aged; Aspergillosis; Aspergillus fumigatus; Female; Fluconazole; Humans; Lung Diseases, Fungal; Pneu | 1990 |
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Antifungal Agents; Anti | 1988 |